Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene

被引:21
|
作者
Lima, Francisco Pignataro [1 ,2 ,4 ,5 ]
Bousquet, Marina [1 ,2 ]
Gomez-Brouchet, Anne [3 ]
de Paiva, Geisilene Russano [3 ]
Amstalden, Eliane Maria Ingrid [5 ]
Soares, Fernando Augusto [6 ]
Dastugue, Nicole [1 ,2 ]
Vassallo, Jose [5 ]
Brousset, Pierre [1 ,2 ]
机构
[1] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France
[2] Univ Toulouse 3, Dept Pathol, F-31062 Toulouse, France
[3] Hop Rangueil, Dept Pathol, Toulouse, France
[4] Purpan Hosp, Cytogenet Lab, Toulouse, France
[5] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, Brazil
[6] Hosp Canc, Dept Pathol, Sao Paulo, Brazil
关键词
BCL2; c-MYC; fluorescence in situ hybridization; FISH; bone; B-cell lymphoma;
D O I
10.1309/CMPGPYTMFRM6RVQR
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We selected a series of 63 primary diffuse large B-cell lymphomas (DLBCLs) of bone collected in tissue microarrays from centers in France and Brazil. These cases were classified according to the expression of antigens associated with germinal center (GC; n = 42) or non-GC (n = 21) stages of B-cell differentiation. By fluorescence in situ hybridization, we found a substantial number of cases with a rearrangement of BCL2 (9132) and c-MYC (n = 3), whereas the PAX5, BCL6, BCL1/cyclin D1, and ALK genes were in germline configuration. It is interesting that I case, with a GC phenotype, showed dual B CL2 and c-MYC rearrangement. The majority of the cases with rearrangements were of the GC phenotype. These results, associated with the lack of BCL6 rearrangement, suggest that bone DLBCL represents a specific group within extranodal B-cell lymphomas.
引用
收藏
页码:723 / 726
页数:4
相关论文
共 50 条
  • [21] MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type
    Nosrati, Anahita
    Monabati, Ahmad
    Sadeghipour, Alireza
    Radmanesh, Fatemeh
    Safaei, Akbar
    Movahedinia, Sajjadeh
    ANNALS OF HEMATOLOGY, 2019, 98 (01) : 169 - 173
  • [22] MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type
    Anahita Nosrati
    Ahmad Monabati
    Alireza Sadeghipour
    Fatemeh Radmanesh
    Akbar Safaei
    Sajjadeh Movahedinia
    Annals of Hematology, 2019, 98 : 169 - 173
  • [23] Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning
    Tavolara, Thomas E.
    Niazi, M. Khalid Khan
    Feldman, Andrew L.
    Jaye, David L.
    Flowers, Christopher
    Cooper, Lee A. D.
    Gurcan, Metin N.
    DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [24] Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
    Zhang, YunXiang
    Wang, Hui
    Ren, Cuiai
    Yu, Hai
    Fang, Wenjia
    Zhang, Na
    Gao, Sumei
    Hou, Qian
    FRONTIERS IN PHARMACOLOGY, 2019, 9
  • [25] Primary mediastinal B-cell lymphoma: Detection of BCL2 gene rearrangements by PCR analysis and FISH
    Dunphy C.H.
    O'Malley D.P.
    Cheng L.
    Fodrie T.Y.
    Perkins S.L.
    Kaiser-Rogers K.
    Journal of Hematopathology, 2008, 1 (2) : 77 - 84
  • [26] Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma
    Rantanen, S
    Monni, O
    Joensuu, H
    Franssila, K
    Knuutila, S
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 1089 - 1098
  • [27] Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
    Hilton, Laura K.
    Collinge, Brett
    Ben-Neriah, Susana
    Alduaij, Waleed
    Shaalan, Haya
    Weng, Andrew P.
    Cruz, Manuela
    Slack, Graham W.
    Farinha, Pedro
    Miyata-Takata, Tomoko
    Boyle, Merrill
    Meissner, Barbara
    Cook, James R.
    Ondrejka, Sarah L.
    Ott, German
    Rosenwald, Andreas
    Campo, Elias
    Amador, Catalina
    Greiner, Timothy C.
    Raess, Philipp W.
    Song, Joo Y.
    Inghirami, Giorgio
    Jaffe, Elaine S.
    Weisenburger, Dennis D.
    Chan, Wing C.
    Beiske, Klaus
    Fu, Kai
    Delabie, Jan
    Pittaluga, Stefania
    Iqbal, Javeed
    Wright, George
    Sehn, Laurie H.
    Savage, Kerry J.
    Mungall, Andrew J.
    Feldman, Andrew L.
    Staudt, Louis M.
    Steidl, Christian
    Rimsza, Lisa M.
    Morin, Ryan D.
    Scott, David W.
    BLOOD, 2024, 144 (05) : 525 - 540
  • [28] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [29] BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients
    Akay, Olga Me Item
    Aras, Beyhan Durak
    Isiksoy, Serap
    Toprak, Cigdem
    Mutlu, Fezan Sahin
    Artan, Sevilhan
    Oner, Ulku
    Gulbas, Zafer
    CANCER GENETICS, 2014, 207 (03) : 87 - 93
  • [30] Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression
    Oh, Eun Ji
    Yang, Woo Ick
    Cheong, June-Won
    Choi, Sung-eun
    Yoon, Sun Och
    HUMAN PATHOLOGY, 2014, 45 (10) : 2043 - 2050